OUP user menu

Coronary Heart Disease

Back to Cardio Image Bank


Circulating microparticle levels in patients with coronary artery disease: a new indicator of vulnerability? - Figure 1

Eur. Heart J. (2011), 32 (16), 1958-1960; 10.1093/eurheartj/ehr055 - Click here to view abstract

Release of microparticles (MPs) into the blood stream following cell activation or apoptosis. MPs released from endothelial cells and/or platelets, characterized by phosphatidylserine exposure and presence of CD31 (CD31+ AnnV+ MPs) may serve as a pronostic marker for major adverse cardiovascular events. In addition, circulating MPs may contribute to the development of athero-thrombosis by promoting endothelial dysfunction, favouring intraplaque angiogenesis and thrombus formation.


Endothelial dysfunction over the course of coronary artery disease - Figure 2

Eur Heart J (2013) 34 (41): 3175-3181; 10.1093/eurheartj/eht351 - Click here to view abstract

Illustration of the reciprocal interaction between endothelial dysfunction, inflammation and the natural history of coronary artery disease. Blue arrows marked with the box ‘ED’ represent processes in which endothelial dysfunction modifies the evolution or prognosis of coronary artery disease. Red arrows represent ways in which coronary artery disease contributes to a worse endothelial function.


Remote ischaemic pre-conditioning in cardiac surgery: benefit or not? - Figure 1

Eur Heart J (2014) 35 (3): 141-143; 10.1093/eurheartj/eht517 - Click here to view the abstract

Possible mechanisms for signal transduction from remote ischaemic tissue (upper arm) to target organ (heart).


How to treat Marfan syndrome: an update

Eur. Heart J. (2015), Fig 1; 10.1093/eurheartj/ehv589 - click here to view abstract

Aortic root growth rates in Marfan patients on beta-blockers (green circles) and those on losartan (red squares), extrapolated from the four published randomized studies.


Back to Cardio Image Bank